Cibc World Market Inc. Grows Holdings in Kenvue Inc. $KVUE

Cibc World Market Inc. grew its position in shares of Kenvue Inc. (NYSE:KVUE) by 112.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 684,567 shares of the company’s stock after purchasing an additional 361,589 shares during the quarter. Cibc World Market Inc.’s holdings in Kenvue were worth $11,111,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. AlphaCore Capital LLC lifted its stake in shares of Kenvue by 9.9% during the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after buying an additional 476 shares during the period. Empirical Finance LLC lifted its stake in shares of Kenvue by 1.8% during the 2nd quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock worth $593,000 after purchasing an additional 491 shares during the period. Altus Wealth Group LLC boosted its holdings in shares of Kenvue by 1.7% during the second quarter. Altus Wealth Group LLC now owns 31,398 shares of the company’s stock worth $657,000 after purchasing an additional 524 shares during the last quarter. J.W. Cole Advisors Inc. grew its position in shares of Kenvue by 3.8% in the second quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock valued at $324,000 after purchasing an additional 574 shares during the period. Finally, Spire Wealth Management increased its stake in Kenvue by 13.5% in the second quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock valued at $102,000 after purchasing an additional 580 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on KVUE shares. Johnson Rice reissued a “neutral” rating on shares of Kenvue in a research note on Tuesday, October 28th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and lowered their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Evercore set a $18.00 price target on shares of Kenvue in a research note on Tuesday, October 28th. Finally, Deutsche Bank Aktiengesellschaft set a $18.00 price objective on shares of Kenvue in a research note on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.46.

Insider Activity at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction on Friday, December 12th. The shares were bought at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the purchase, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.68% of the stock is currently owned by corporate insiders.

Kenvue Price Performance

KVUE opened at $18.70 on Friday. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a 50 day moving average of $17.38 and a two-hundred day moving average of $17.76. The company has a market cap of $35.82 billion, a P/E ratio of 24.93 and a beta of 0.59. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be given a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.